Cord Blood Transplantation Provided Long-term Remission in a Case of Adult T-cell Leukemia-lymphoma (ATL) with Myelofibrosis.

A 53-year-old man was diagnosed with adult T-cell leukemia-lymphoma (ATL) acute type transformed from chronic type. A bone marrow analysis showed diffuse infiltration of abnormal lymphocytes and diffuse fibrotic change. He received unrelated cord blood transplantation (CBT) following reduced-intensity conditioning with complete remission of ATL after two courses of chemotherapy and achieved neutrophil and platelet engraftment. At 99 days after CBT, a bone marrow biopsy showed apparent resolution of myelofibrosis. These results suggest the therapeutic potential of CBT for patients with chemosensitive ATL with myelofibrosis.

[1]  S. Honda,et al.  Characteristic patterns of relapse after allogeneic hematopoietic SCT for adult T-cell leukemia–lymphoma: a comparative study of recurrent lesions after transplantation and chemotherapy by the Nagasaki Transplant Group , 2015, Bone Marrow Transplantation.

[2]  M. Seto,et al.  Recent advances in the treatment of adult T-cell leukemia-lymphomas , 2015, Cancer science.

[3]  K. Akashi,et al.  Treatment of patients with adult T cell leukemia/lymphoma with cord blood transplantation: a Japanese nationwide retrospective survey. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[4]  Michael Frank Harris,et al.  Lymphoma , 1990, BMJ : British Medical Journal.

[5]  糸永 英弘.  Treatment of relapsed adult T-cell leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation : the Nagasaki transplant group experience , 2013 .

[6]  S. Honda,et al.  Distinct clinical features of infectious complications in adult T cell leukemia/lymphoma patients after allogeneic hematopoietic stem cell transplantation: a retrospective analysis in the Nagasaki transplant group. , 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[7]  Y. Miyazaki,et al.  Feasibility of cord blood transplantation in chemosensitive adult T-cell leukemia/lymphoma: a retrospective analysis of the Nagasaki Transplantation Network , 2013, International Journal of Hematology.

[8]  K. Ohshima,et al.  Unrelated cord blood transplantation for patients with adult T-cell leukemia/lymphoma: experience at a single institute , 2012, International Journal of Hematology.

[9]  K. Matsuo,et al.  Impact of graft-versus-host disease on outcomes after allogeneic hematopoietic cell transplantation for adult T-cell leukemia: a retrospective cohort study. , 2012, Blood.

[10]  Takuya FukushimaJun.  Allogeneic hematopoietic stem cell transplantation for ATL with central nervous system involvement: The Nagasaki Transplant Group experience , 2011 .

[11]  K. Matsuo,et al.  Transplantation of allogeneic hematopoietic stem cells for adult T-cell leukemia: a nationwide retrospective study. , 2010, Blood.

[12]  Koichi Takahashi,et al.  Successful engraftment after reduced-intensity umbilical cord blood transplantation for myelofibrosis. , 2010, Blood.

[13]  P. Rameshwar,et al.  Peripheral monocytes and CD4+ cells are potential Sources for increased circulating levels of TGF‐β and substance P in autoimmune myelofibrosis , 2006, American journal of hematology.

[14]  B. Juliar,et al.  Evaluation of stroma in human immunodeficiency virus/acquired immunodeficiency syndrome-affected bone marrows and correlation with CD4 counts. , 2005, Archives of pathology & laboratory medicine.

[15]  R. Hoffman,et al.  Allogeneic hematopoietic stem-cell transplantation with reduced-intensity conditioning in intermediate- or high-risk patients with myelofibrosis with myeloid metaplasia. , 2005, Blood.

[16]  M. Tomonaga,et al.  Allogeneic hematopoietic stem cell transplantation provides sustained long-term survival for patients with adult T-cell leukemia/lymphoma , 2005, Leukemia.

[17]  S. Okabe,et al.  Peripheral T-cell lymphoma together with myelofibrosis with elevated plasma transforming growth factor-β1 , 2005 .

[18]  S. Okabe,et al.  Peripheral T-cell lymphoma together with myelofibrosis with elevated plasma transforming growth factor-beta1. , 2005, Leukemia & lymphoma.

[19]  K. Besien.  Transplantation for myelofibrosis: yes! But for whom? , 2003 .

[20]  S. Gottesman,et al.  T Cell Lymphoma Associated with Myelofibrosis , 2003, Leukemia & lymphoma.

[21]  S. Mano,et al.  Peripheral T-cell Lymphoma Presenting with Rapidly Progressing Myelofibrosis , 2003, Leukemia & lymphoma.

[22]  K. Ohshima,et al.  Cytotoxic T‐cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF‐β , 2001 .

[23]  K. Ohshima,et al.  Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta. , 2001, European journal of haematology.

[24]  Y. Kodera,et al.  Improved outcome of adult T cell leukemia/lymphoma with allogeneic hematopoietic stem cell transplantation , 2001, Bone Marrow Transplantation.

[25]  A. Tefferi.  Myelofibrosis with myeloid metaplasia. , 2000, The New England journal of medicine.

[26]  H. Deeg,et al.  Allogeneic stem cell transplantation for agnogenic myeloid metaplasia: a European Group for Blood and Marrow Transplantation, Société Française de Greffe de Moelle, Gruppo Italiano per il Trapianto del Midollo Osseo, and Fred Hutchinson Cancer Research Center Collaborative Study. , 1999, Blood.

[27]  M. Shimoyama,et al.  Diagnostic criteria and classification of clinical subtypes of adult T‐cell leukaemia‐lymphoma , 1991, British journal of haematology.

[28]  O. Katoh,et al.  Transforming growth factor-beta regulates growth as well as collagen and fibronectin synthesis of human marrow fibroblasts. , 1989, British journal of haematology.

[29]  H. Deeg,et al.  Adverse effect of severe marrow fibrosis on hematologic recovery after chemoradiotherapy and allogeneic bone marrow transplantation. , 1986, Blood.